Par Drugs & Chemicals Ltd Share Price – NSE

Pharmaceuticals, Small Cap

Net profit of Par Drugs & Chemicals declined 48.48% to Rs 0.85 crore in the quarter ended March 2026 as against Rs 1.65 crore during the previous quarter ended March 2025. Sales declined 12.18% to Rs 19.61 crore in the quarter ended March 2026 as against Rs 22.33 crore during the previous quarter ended March 2025.

For the full year,net profit declined 1.87% to Rs 13.11 crore in the year ended March 2026 as against Rs 13.36 crore during the previous year ended March 2025. Sales rose 2.66% to Rs 103.66 crore in the year ended March 2026 as against Rs 100.97 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 14 May 2026.

Net profit of Par Drugs & Chemicals rose 727.59% to Rs 4.80 crore in the quarter ended December 2025 as against Rs 0.58 crore during the previous quarter ended December 2024. Sales rose 37.23% to Rs 29.34 crore in the quarter ended December 2025 as against Rs 21.38 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 10 February 2026.

Powered by Capital Market - Live News